首页> 外文OA文献 >Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab

【2h】

Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab

机译：影响人体表皮生长因子受体2阳性乳腺癌患者患者免疫生存的因素，接受佐剂曲妥珠单抗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
SEYDA GÜNDÜZ; SEMA SEZGIN GÖKSU; DENIZ ARSLAN; ALI MURAT TATLI; MÜKREMIN UYSAL; UMUT RIZA GÜNDÜZ; MERT MAHSUNI SEVINÇ; HASAN SENOL COŞKUN; HAKAN BOZCUK; HASAN MUTLU; BURHAN SAVAS;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer [J] . KiessA.P., McArthurH.L., MahoneyK., Cancer: A Journal of the American Cancer Society . 2012,第8期

机译：辅助曲妥珠单抗可减少接受保乳疗法治疗淋巴结阴性，人表皮生长因子受体2阳性乳腺癌的女性的局部复发
2. Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer [J] . Printz Carrie Cancer: A Journal of the American Cancer Society . 2019,第8期

机译：替代升级的赫卡斯托朱卢斯·赫赛汀提高人体表皮生长因子受体2阳性乳腺癌患者的存活
3. Factors Influencing Adjuvant Chemotherapy and Trastuzumab Choice in Older Human Epidermal Growth Factor Receptor 2-positive Breast Cancer Patients [J] . Yan Fang, Zheng Wang, Jiayi Wu, Journal of Cancer . 2020,第9期

机译：影响辅助化疗和曲妥珠单抗在较老的人表皮生长因子受体2阳性乳腺癌患者中的因素
4. Identification of Human Epidermal Growth Factor Receptor 2 Antagonist In Silico for Breast Cancer Therapy, Derived from Indonesian Phytochemicals [C] . Tuti Ratnasari, Dono indarto, Raden Ajeng Sri Wulandari, International Conference on Biomedical Engineering . 2018

机译：人类表皮生长因子受体2拮抗剂在二氧化硅中用于印尼治疗的印尼植物化学成分的鉴定。
5. Indirect Costs Associated with Human Epidermal Growth Factor Receptor Positive (HER2+) Metastatic Breast Cancer [D] . Wright, Phoebe. 2020

机译：与人表皮生长因子受体阳性（HER2 +）转移性乳腺癌相关的间接成本
6. Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab [O] . SEYDA GÜNDÜZ, SEMA SEZGIN GÖKSU, DENIZ ARSLAN, -1

机译：接受曲妥珠单抗辅助治疗的人表皮生长因子受体2阳性乳腺癌患者无病生存的因素
7. Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer [O] . Ana P. Kiess, Heather L. McArthur, Kathleen Mahoney, 2011

机译：佐剂曲妥珠单抗降低了接受淋巴结阴性的哺乳治疗的妇女的患者患者，人表皮生长因子受体2阳性乳腺癌

Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab

著录项

引文网络

相似文献

相关主题

期刊订阅